BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

N-Of-One Executive Joins OBR Oncology Editorial Board As Precision Medicine Section Editor And Contributing Writer


1/29/2014 9:39:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass., January 29, 2014 – N-of-One, Inc., the leading provider of molecular interpretation and therapeutic strategies for precision medicine in cancer care, today announced that Jennifer Levin Carter, MD, PhD, Chief Medical Officer and Founder, has joined the editorial board of Oncology Business Review (OBR), a comprehensive digital platform for oncology-focused news and information, as Precision Medicine Section Editor. Dr. Carter will contribute articles on advances in precision medicine for cancer treatment focused on the point of care, based on N-of-One’s extensive five year experience interpreting more than 6,000 tumors.

Dr. Carter’s first contributed article appeared in the January 2014 issue of OBR Oncology’s monthly publication OBR green:

Three Industry Developments in Precision Medicine in 2013 Set the Stage for Broader Availability

“We are honored to welcome Dr. Carter to our editorial board and as a regular contributor to OBR,” said Don Sharpe, President of OBR. “Our focus at OBR is on providing passionate, expert original coverage of news and trends affecting the oncology field, and as founder of the leading company providing molecular interpretation for personalized cancer medicine, Dr. Carter brings a unique perspective and knowledge to her new role as Precision Medicine Section Editor that will be very valuable to our readers.”

About N-of-One

N-of-One, a leader in precision medicine, leverages its world-class team of experts to translate molecular data specific to each patient into state-of-the-art, clinically actionable insights and therapeutic options focused on the point of care. Using the company’s PrecisionWorks™ knowledge integration platform and framework, N-of-One’s team of experts has delivered more than 6,000 personalized, interpretative roadmaps to oncologists and patients worldwide, through partnerships to provide interpretation services for leading diagnostic companies (such as Foundation Medicine and Clarient), through agreements with provider networks (such as Fox Chase Cancer Center in Philadelphia), directly to oncologists or through employee access benefit programs (such as Life Technologies). N-of-One does not provide medical advice or promote any product or service. For more information, please visit www.n-of-one.com or call 617-202-9808.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES